CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PharmaTimes
Original article

R1 Therapeutics begins global phase 2b trial of AP306 for hyperphosphatemia

Phase 2
Related Companies

Read the original article

Published by PharmaTimes on July 22, 2026 1:01 PM

Read Original